Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Keratin 10 Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Keratin 10 in FACS, IF und IHC (p). Er zeigt eine Reaktivität gegenüber Human und Maus.
Produktnummer ABIN3026651

Kurzübersicht für Keratin 10 Antikörper (ABIN3026651)

Target

Alle Keratin 10 (KRT10) Antikörper anzeigen
Keratin 10 (KRT10)

Reaktivität

  • 192
  • 90
  • 58
  • 48
  • 38
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human, Maus

Wirt

  • 103
  • 94
  • 2
Maus

Klonalität

  • 136
  • 63
Monoklonal

Konjugat

  • 99
  • 14
  • 10
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Keratin 10 Antikörper ist unkonjugiert

Applikation

  • 129
  • 91
  • 55
  • 52
  • 39
  • 30
  • 28
  • 21
  • 20
  • 14
  • 13
  • 11
  • 10
  • 8
  • 2
  • 2
  • 2
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

LH2
  • Produktmerkmale

    This antibody recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation, it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    Skin extract from a human psoriasis patient was used as the immunogen for this Cytokeratin 10 antibody.

    Isotyp

    IgG1
  • Applikationshinweise

    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the antibody to be titered up or down for optimal performance.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 1  mM EDTA,  pH 8-9, for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. FACS: 0.5-1 μg/million cells,IF: 0.5-1 μg/mL,IHC (FFPE): 0.5-1 μg/mL for 30 minutes at RT (1),Prediluted format : incubate for 30 min at RT (2)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Konservierungsmittel

    Azide free

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the Cytokeratin 10 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target

    Keratin 10 (KRT10)

    Andere Bezeichnung

    Cytokeratin 10

    Hintergrund

    This antibody recognizes a protein of 56.5  kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation, it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.

    Gen-ID

    3858
Sie sind hier:
Chat with us!